Document is current
Any future updates will be listed below
-
Authors
Cartry, Jérôme https://orcid.org/0000-0002-1693-1323
Bedja, Sabrina
Boilève, Alice
Mathieu, Jacques R. R.
Gontran, Emilie
Annereau, Maxime
Job, Bastien
Mouawia, Ali
Mathias, Pierre
De Baère, Thierry
Italiano, Antoine
Besse, Benjamin
Sourrouille, Isabelle
Gelli, Maximiliano
Bani, Mohamed-Amine
Dartigues, Peggy
Hollebecque, Antoine
Smolenschi, Cristina
Ducreux, Michel
Malka, David
Jaulin, Fanny
-
Funding
Funding for this research was provided by:
ANR (ANR-20-CE13-0031-01, ANR-21-RHUS-0005)
INCa (2020-1-PLBIO-04-IGR-1)
Fondation Gustave Roussy (Fundraising against CRC, Mars Bleu)
Inserm Cancer (3R program (20CR046-00))
- License Information
-
More Information
Article History
Received: 30 June 2023
Accepted: 6 October 2023
First Online: 25 October 2023
Declarations
:
: The human study protocols followed all relevant ethical regulations in accordance with the Declaration of Helsinki principles. Fresh tumor tissues were obtained after surgery or core needle biopsy within two institutional review board-approved, ethics committee-approved precision medicine studies (STING, NCT0493252; MATCH-R, NCT02517892). All patients signed informed consent.
: The patient whose case is presented signed the MATCH-R trial consent form (NCT02517892).
: F.J and J.C are co-founders of ORAKL Oncology. The authors declare that they have no competing interests.
